Glenmark Pharma soars as its arm receives USFDA’s approval for Lacosamide Tablets

glenmark pharmas arm receives usfdas approval for fulvestrant injection

Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at Rs. 445.00 and has touched a high and low of Rs. 457.85 and Rs. 445.00 respectively. So far 42623 shares were traded on the counter. The BSE … Read more

Glenmark Pharmaceuticals shines on reporting 17% rise in Q2 consolidated net profit

glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals is currently trading at Rs. 533.95, up by 10.30 points or 1.97% from its previous closing of Rs. 523.65 on the BSE. The scrip opened at Rs. 523.00 and has touched a high and low of Rs. 539.50 and Rs. 523.00 respectively. So far 77079 shares were traded on the counter. The BSE … Read more

Glenmark Pharmaceuticals’ Q2 consolidated net profit jumps 93%

Glenmark Pharmaceuticals has reported results for second quarter ended September 30, 2018. The company has reported over 2-fold jump in its net profit of Rs 747.56 crore for the quarter under review as compared to Rs 327.88 crore for the same quarter in the previous year. Total income of the company increased by 28.48% at … Read more

BREAKING NEWS:
Get 365-day plans under ₹2000 before price hike! IPL 2026: Vaibhav Sooryavanshi Leads in Sixes! Rajasthan Royals lose despite Sooryavanshi’s fiery innings: Key culprits!